Recursion Pharmaceuticals Inc Asset Turnover Ratio (RXRX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Recursion Pharmaceuticals Inc   (NASDAQ: RXRX)
 

Recursion Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Recursion Pharmaceuticals Inc 's asset turnover ratio, the ratio that measures the ability of Recursion Pharmaceuticals Inc 's assets to generate revenue, sequentially decreased to 0.04 in the second quarter (Jun 30 2026), which does not come as a surprise, as the Recursion Pharmaceuticals Inc continue to experience difficult business climate.

Within sector 61 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 3432, from total ranking in the first quarter 2026 at 4128.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RXRX Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -6.89 % 2.63 % 6.43 % 105.89 % 77.85 %
Y / Y Revenue Change -60.1 % -56.11 % 681.74 % -80.16 % 33.34 %
Asset Turnover Ratio (TTM) 0.04 0.05 0.05 0.03 0.06
RXRX's Total Ranking # 3432 # 4128 # 3792 # 3546 # 3586
Seq. Asset Change -9.47 % -9.13 % 5.33 % 7.46 % -0.22 %
Seq. Revenue Change 18.51 % -81.79 % 586.72 % -73.08 % 30.37 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 62
Healthcare Sector # 517
Overall Market # 3432

Asset Turnover Ratio Statistics
High Average Low
0.1 0.06 0.02
(Sep 30 2024)   (Dec 31 2021)




RXRX Company Profile • Back to RXRX Efficiency Comparisons • Compare RXRX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
Kura Oncology Inc   0.12 $ 77.225  Millions$ 657.022  Millions
Arcus Biosciences Inc   0.12 $ 117.000  Millions$ 1,008.500  Millions
Arcturus Therapeutics Holdings Inc   0.11 $ 29.368  Millions$ 255.803  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
Surrozen Inc   0.11 $ 11.511  Millions$ 107.272  Millions
C4 Therapeutics Inc   0.11 $ 35.039  Millions$ 328.207  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Ginkgo Bioworks Holdings Inc   0.10 $ 111.863  Millions$ 1,082.996  Millions
Zymeworks Inc   0.09 $ 37.127  Millions$ 404.744  Millions
Nektar Therapeutics  0.09 $ 54.589  Millions$ 610.038  Millions
Bolt Biotherapeutics Inc   0.09 $ 4.700  Millions$ 52.543  Millions
Therapeuticsmd Inc   0.09 $ 3.270  Millions$ 37.859  Millions
Lenz Therapeutics Inc   0.08 $ 21.475  Millions$ 256.428  Millions
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Longeveron Inc   0.08 $ 1.187  Millions$ 15.629  Millions
Armata Pharmaceuticals Inc   0.07 $ 6.034  Millions$ 81.537  Millions
Intellia Therapeutics Inc   0.07 $ 59.506  Millions$ 845.836  Millions
Cytomx Therapeutics Inc   0.07 $ 18.302  Millions$ 262.601  Millions
Kymera Therapeutics Inc   0.07 $ 105.000  Millions$ 1,539.829  Millions
Catheter Precision Inc   0.07 $ 1.915  Millions$ 28.322  Millions
Ocugen Inc   0.06 $ 4.580  Millions$ 70.556  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions
EBR Systems, Inc.  0.06 $ 6.446  Millions$ 105.295  Millions
Caribou Biosciences Inc   0.06 $ 10.035  Millions$ 165.531  Millions
Grail Inc   0.06 $ 165.263  Millions$ 2,792.551  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.